Phytochemical and Herbal Therapeutic Approaches in Polycystic Ovarian Disease-induced Infertility: Mechanistic and Clinical Perspectives

Polycystic Ovarian Disease (PCOD) is a type of endocrine and metabolic disorder commonly found in women of childbearing age. It can cause irregular menstrual periods or failure to ovulate. Hyperandrogenism, ovulatory dysfunction, insulin resistance, chronic low-grade inflammation, and oxidative stress characterize PCOD. Many symptoms of PCOD lead to early diagnosis and identification are difficult due to the lack of any specific test for diagnosis. There are numerous metabolic and reproductive complications complicating the prognosis and options of individualized treatment for women diagnosed with PCOD. Recent advances in high-throughput technology and multi-omics approaches (genomics, transcriptomics, proteomics, and metabolomics) have helped scientists develop a better understanding of the mechanisms behind PCOD-related infertility at a molecular level. The development and use of multi-omics technologies have allowed the identification of various biomarkers related to hormonal, metabolic, and ovarian dysfunction. The use of Artificial Intelligence (AI) and Machine Learning (ML) has been increased to develop predictive models for individual patient stratification and management. Interest in using phytochemicals and herbal therapies as potential adjunct therapies for treating PCOD-related infertility has been increasing. Research indicates many bioactive compounds found in plants, including flavonoids, polyphenols, alkaloids, and terpenoids, have the ability to improve insulin sensitivity, regulate hormone production, and suppress both inflammation and oxidative stress. There is emerging evidence indicating that these adjunct therapies may restore ovulation and improve reproductive outcomes in women diagnosed with PCOD. The purpose of this review is to highlight recent advances and evidence regarding the use of bioactive compounds as supplements for women with PCOD/PCOS throughout their reproductive lives through continued integration of these therapies into evidenc

View article page

Download PDF